This study investigates advanced pancreatic cancer. It involves the use of an investigational medication combined with standard chemotherapy to examine its effects on the disease.
The study evaluates the safety and effectiveness of the investigational medication in combination with standard chemotherapy. It looks at how well the treatment works and how safe it is for patients.
- Who can participate: Adults aged 18 and older with advanced pancreatic cancer who have not received prior systemic treatment may participate. Key factors include having a measurable lesion and adequate organ function.
- Study details: Participants will receive an investigational medication with standard chemotherapy. Some may also receive an additional investigational treatment.
How understandable was the trial content above?
Hard to understand
Easy to understand